BAYHILL THERAPEUTICS
Bayhill Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapeutics for autoimmune diseases. The company uses its therapeutic BHT-DNA platform to develop a pipeline of treatment candidates for autoimmune diseases. Its products in clinical pipeline include BHT-3021, which is in Phase I/II clinical trial for reducing or eliminating the immune system’s attack on the pancreas; BHT-3009, which completed its Phase II trial for the treatment ... of multiple sclerosis; and BHT-3034, which is in preclinical studies for the treatment of myasthenia gravis. The company was formerly known as Tolerion, Inc. and changed its name to Bayhill Therapeutics, Inc. in November 2002. Bayhill Therapeutics, Inc. was founded in 2000 and is headquartered in Palo Alto, California.
BAYHILL THERAPEUTICS
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2000-01-01
Address:
Portola Valley, California, United States
Country:
United States
Website Url:
http://www.bayhilltx.com
Total Employee:
51+
Status:
Active
Contact:
650-575-1702
Email Addresses:
[email protected]
Total Funding:
61.2 M USD
Technology used in webpage:
Nginx Baidu Cloud
Current Advisors List
Current Employees Featured
Founder
Investors List
DeNovo Ventures
DeNovo Ventures investment in Venture Round - Bayhill Therapeutics
Latterell Venture Partners
Latterell Venture Partners investment in Venture Round - Bayhill Therapeutics
Montreux Equity Partners
Montreux Equity Partners investment in Venture Round - Bayhill Therapeutics
U.S. Venture Partners
U.S. Venture Partners investment in Venture Round - Bayhill Therapeutics
Boston Life Science Venture
Boston Life Science Venture investment in Venture Round - Bayhill Therapeutics
Pappas Ventures
Pappas Ventures investment in Venture Round - Bayhill Therapeutics
The Vertical Group
The Vertical Group investment in Venture Round - Bayhill Therapeutics
Pac-Link
Pac-Link investment in Venture Round - Bayhill Therapeutics
CMEA Ventures
CMEA Ventures investment in Venture Round - Bayhill Therapeutics
Morgenthaler Ventures
Morgenthaler Ventures investment in Venture Round - Bayhill Therapeutics
